Christopher K. Murray, CHIEF TECHNICAL OPERATIONS at Blueprint Medicines Corp (BPMC), sold 5,000 shares at $100.00 ($500K) on 2024-02-28, disclosed to the SEC on 2024-03-01.
Scheduled sale ($500k) by CHIEF TECHNICAL OPERATIONS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BPMC | SELL | 2023-12-11 | $375K | — | Filing → |
| BPMC | SELL | 2023-12-06 | $43K | — | Filing → |
| BPMC | SELL | 2023-10-30 | $34K | — | Filing → |